A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The center for the fight against cancer in Lyon and Rhône-Alpes, the Léon Bérard Center is a hospital specializing in oncology. The Léon Bérard Center is a member of UNICANCER (National Federation of Cancer Control Centers). This group brings together 20 French hospitals dedicated to cancer patients.
Lyon, France Clinical Trial Location
Centre Léon Bérard
28 Prom. Léa et Napoléon Bullukian,
69008 Lyon, France